117 related articles for article (PubMed ID: 9504645)
1. The relative power of heat-precipitation nephelometric and clottable (Clauss) fibrinogen in the prediction of ischaemic heart disease: the Caerphilly and Speedwell studies.
Sweetnam PM; Yarnell JW; Lowe GD; Baker IA; O'Brien JR; Rumley A; Etherington MD; Whitehead PJ; Elwood PC
Br J Haematol; 1998 Mar; 100(3):582-8. PubMed ID: 9504645
[TBL] [Abstract][Full Text] [Related]
2. Direct comparisons of three alternative plasma fibrinogen assays with the von Clauss assay in prediction of cardiovascular disease and all-causes mortality: the Scottish Heart Health Extended Cohort.
Peters SA; Woodward M; Rumley A; Koenig W; Tunstall-Pedoe H; Lowe GD
Br J Haematol; 2013 Aug; 162(3):392-9. PubMed ID: 23701042
[TBL] [Abstract][Full Text] [Related]
3. Fibrinogen, viscosity and the 10-year incidence of ischaemic heart disease.
Sweetnam PM; Thomas HF; Yarnell JW; Beswick AD; Baker IA; Elwood PC
Eur Heart J; 1996 Dec; 17(12):1814-20. PubMed ID: 8960422
[TBL] [Abstract][Full Text] [Related]
4. Haemostatic factors associated with ischaemic heart disease in men aged 45 to 64 years. The Speedwell study.
Baker IA; Eastham R; Elwood PC; Etherington M; O'Brien JR; Sweetnam PM
Br Heart J; 1982 May; 47(5):490-4. PubMed ID: 7073911
[TBL] [Abstract][Full Text] [Related]
5. Comparison of plasma fibrinogen by Clauss, prothrombin time-derived, and immunonephelometric assays in a general population: implications for risk stratification by thirds of fibrinogen.
Rumley A; Woodward M; Hoffmeister A; Koenig W; Lowe GD
Blood Coagul Fibrinolysis; 2003 Feb; 14(2):197-201. PubMed ID: 12632032
[TBL] [Abstract][Full Text] [Related]
6. Fibrinogen, viscosity and white blood cell count predict myocardial, but not cerebral infarction: evidence from the Caerphilly and Speedwell cohort.
Baker IA; Pickering J; Elwood PC; Bayer A; Ebrahim S
Thromb Haemost; 2002 Mar; 87(3):421-5. PubMed ID: 11916073
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein, fibrin D-dimer, and risk of ischemic heart disease: the Caerphilly and Speedwell studies.
Lowe GD; Sweetnam PM; Yarnell JW; Rumley A; Rumley C; Bainton D; Ben-Shlomo Y
Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1957-62. PubMed ID: 15308549
[TBL] [Abstract][Full Text] [Related]
8. Comparison of weight in middle age, weight at 18 years, and weight change between, in predicting subsequent 14 year mortality and coronary events: Caerphilly Prospective Study.
Yarnell JW; Patterson CC; Thomas HF; Sweetnam PM
J Epidemiol Community Health; 2000 May; 54(5):344-8. PubMed ID: 10814654
[TBL] [Abstract][Full Text] [Related]
9. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The Caerphilly and Speedwell collaborative heart disease studies.
Yarnell JW; Baker IA; Sweetnam PM; Bainton D; O'Brien JR; Whitehead PJ; Elwood PC
Circulation; 1991 Mar; 83(3):836-44. PubMed ID: 1999035
[TBL] [Abstract][Full Text] [Related]
10. Degree of agreement in plasma fibrinogen among two functional and one immunonephelometric assays.
Magnani B; Fenton T; Lapp C; Brugnara C
Am J Clin Pathol; 1997 May; 107(5):527-33. PubMed ID: 9128264
[TBL] [Abstract][Full Text] [Related]
11. Exercise, fibrinogen, and other risk factors for ischaemic heart disease. Caerphilly Prospective Heart Disease Study.
Elwood PC; Yarnell JW; Pickering J; Fehily AM; O'Brien JR
Br Heart J; 1993 Feb; 69(2):183-7. PubMed ID: 8435246
[TBL] [Abstract][Full Text] [Related]
12. Plasma fibrinogen--an independent risk factor for ischaemic heart disease.
Jose J; Selvakumar D; Selvakumar R; Kanagasapabathy AS; Jeyaseelan L
Indian Heart J; 1998; 50(1):45-8. PubMed ID: 9583286
[TBL] [Abstract][Full Text] [Related]
13. Biochemistry and measurement of fibrinogen.
Nieuwenhuizen W
Eur Heart J; 1995 Mar; 16 Suppl A():6-10; discussion 10. PubMed ID: 7796833
[TBL] [Abstract][Full Text] [Related]
14. Does sticky blood predict a sticky end? Associations of blood viscosity, haematocrit and fibrinogen with mortality in the West of Scotland.
Woodward M; Rumley A; Tunstall-Pedoe H; Lowe GD
Br J Haematol; 2003 Aug; 122(4):645-50. PubMed ID: 12899720
[TBL] [Abstract][Full Text] [Related]
15. Associations of the HDL2 and HDL3 cholesterol subfractions with the development of ischemic heart disease in British men. The Caerphilly and Speedwell Collaborative Heart Disease Studies.
Sweetnam PM; Bolton CH; Yarnell JW; Bainton D; Baker IA; Elwood PC; Miller NE
Circulation; 1994 Aug; 90(2):769-74. PubMed ID: 8044946
[TBL] [Abstract][Full Text] [Related]
16. Automated nephelometry of fibrinogen: analytical performance and observations during thrombolytic therapy.
Hoffmann JJ; Verhappen MA
Clin Chem; 1988 Oct; 34(10):2135-40. PubMed ID: 3168233
[TBL] [Abstract][Full Text] [Related]
17. A performance evaluation of commercial fibrinogen reference preparations and assays for Clauss and PT-derived fibrinogen.
Mackie J; Lawrie AS; Kitchen S; Gaffney PJ; Howarth D; Lowe GD; Martin J; Purdy G; Rigsby P; Rumley A
Thromb Haemost; 2002 Jun; 87(6):997-1005. PubMed ID: 12083508
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the fibrinogen Clauss assay and the fibrinogen PT derived method in patients with dysfibrinogenemia.
Miesbach W; Schenk J; Alesci S; Lindhoff-Last E
Thromb Res; 2010 Dec; 126(6):e428-33. PubMed ID: 20947138
[TBL] [Abstract][Full Text] [Related]
19. Plasma HMW fibrinogen in patients with ischaemic heart disease.
Munkvad S; Nieuwenhuizen W; Jespersen J
Scand J Clin Lab Invest; 1990 May; 50(3):347-9. PubMed ID: 2353165
[TBL] [Abstract][Full Text] [Related]
20. Height: a risk marker for ischaemic heart disease: prospective results from the Caerphilly and Speedwell Heart Disease Studies.
Yarnell JW; Limb ES; Layzell JM; Baker IA
Eur Heart J; 1992 Dec; 13(12):1602-5. PubMed ID: 1289087
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
